Article info
Original research
Clinical relevance of high–intermediate risk endometrial cancer according to European risk classification
- Correspondence to Dr Agnieszka Rychlik, Gynecologic Oncology, Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, 02-781 Warsaw, Poland; agarychlik{at}gmail.com
Citation
Clinical relevance of high–intermediate risk endometrial cancer according to European risk classification
Publication history
- Received June 6, 2020
- Revision received July 24, 2020
- Accepted July 27, 2020
- First published August 18, 2020.
Article Versions
- Previous version (18 August 2020).
- You are currently viewing a Previous version of this article (25 September 2020).
- View the most recent version of this article
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2020. No commercial re-use. See rights and permissions. Published by BMJ.